{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:30:09Z","timestamp":1785814209937,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.xphs.2020.09.051","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:02:53Z","timestamp":1602021773000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Comprehensive Ocular and Systemic Pharmacokinetics of Brinzolamide in Rabbits After Intracameral, Topical, and Intravenous Administration"],"prefix":"10.1016","volume":"110","author":[{"given":"Vatsala","family":"Naageshwaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Pekka","family":"Ranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenwood","family":"Gum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Bhoopathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"del Amo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2020.09.051_bib1","first-page":"391","article-title":"The flow of aqueous humor in the human eye","volume":"80","author":"Brubaker","year":"1982","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.051_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: a review","volume":"4","author":"Goel","year":"2010","journal-title":"Open Ophthalmol J"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.051_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jop.2014.0067","article-title":"Pharmacotherapy of glaucoma","volume":"31","author":"Schmidl","year":"2015","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.051_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","article-title":"Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors","volume":"19","author":"Sugrue","year":"2000","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.051_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1006\/phrs.1997.0167","article-title":"Comparative effects on intraocular pressure between systemic and topical carbonic anhydrase inhibitors: a clinical masked, cross-over study","volume":"35","author":"Centofanti","year":"1997","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.xphs.2020.09.051_bib7","series-title":"Analytical Profiles of Drug Substances and Excipients","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0099-5428(08)60621-8","article-title":"Brinzolamide","author":"Hall","year":"1999"},{"issue":"20","key":"10.1016\/j.xphs.2020.09.051_bib8","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J\u00a0Med Chem"},{"issue":"9","key":"10.1016\/j.xphs.2020.09.051_bib9","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.xphs.2017.04.061","article-title":"Impact of chemical structure on conjunctival drug permeability: adopting porcine conjunctiva and cassette dosing for construction of in silico model","volume":"106","author":"Ramsay","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.09.051_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","article-title":"Corneal and conjunctival drug permeability: systematic comparison and pharmacokinetic impact in the eye","volume":"119","author":"Ramsay","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2020.09.051_bib11","unstructured":"Absorption Systems LLC, Data on File."},{"key":"10.1016\/j.xphs.2020.09.051_bib12","first-page":"S813","article-title":"Brinzolamide (AL-4862) suspension is a new topically active carbonic anhydrase inhibitor in the Dutch-belted rabbits and cynomolgus monkey","author":"Dean","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.051_bib13","first-page":"4","article-title":"Effects of 1% topical brinzolamide on intraocular pressure in healthy dogs","volume":"44","author":"Dower","year":"2018","journal-title":"Acta Sci Vet"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.051_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/vop.12679","article-title":"The effects of topical dorzolamide 2% and brinzolamide 1%, either alone or combined with timolol 0.5%, on intraocular pressure, pupil diameter, and heart rate in healthy cats","volume":"23","author":"Slenter","year":"2020","journal-title":"Vet Ophthalmol"},{"issue":"7","key":"10.1016\/j.xphs.2020.09.051_bib15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2746\/042516408X297426","article-title":"Effects of topical administration of 1% brinzolamide on intraocular pressure in clinically normal horses","volume":"40","author":"Germann","year":"2008","journal-title":"Equine Vet J"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.xphs.2020.09.051_bib16","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/S0039-6257(99)00108-3","article-title":"Preclinical overview of brinzolamide","volume":"44","author":"DeSantis","year":"2000","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.xphs.2020.09.051_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0002-9394(14)77735-9","article-title":"Penetration routes of topically applied eye medications","volume":"85","author":"Doane","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xphs.2020.09.051_bib18","series-title":"Ophthalmic Drug Delivery","first-page":"151","article-title":"The importance of optimizing corneal penetration","author":"Schoenwald","year":"1987"},{"issue":"8","key":"10.1016\/j.xphs.2020.09.051_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jps.2600760802","article-title":"Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea","volume":"76","author":"Ahmed","year":"1987","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.09.051_bib20","first-page":"16","article-title":"Ocular pharmacology","volume":"vol. 69","author":"Maurice","year":"1984"},{"issue":"3","key":"10.1016\/j.xphs.2020.09.051_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/jop.1985.1.309","article-title":"Corneal penetration and ocular bioavailability of drugs","volume":"1","author":"Burstein","year":"1985","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.xphs.2020.09.051_bib22","volume":"vol. 12","author":"Gelatt","year":"2013"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.051_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2004.07.001","article-title":"Model of transient drug diffusion across cornea","volume":"99","author":"Zhang","year":"2004","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2020.09.051_bib24","doi-asserted-by":"crossref","first-page":"105553","DOI":"10.1016\/j.ejps.2020.105553","article-title":"Topical ocular pharmacokinetics and bioavailability for a cocktail of timolol, betaxolol and atenolol in rabbits","author":"Fayyaz","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2020.09.051_bib25","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ophtha.2007.12.004","article-title":"NIH public access","volume":"115","author":"Browning","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xphs.2020.09.051_bib26","unstructured":"AZOPT\u00ae EMA Summary Report. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-discussion\/azopt-epar-scientific-discussion_en.pdf Accessed August 13, 2020"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.051_bib27","first-page":"588","article-title":"Ocular intracameral pharmacokinetics for a cocktail of timolol, betaxolol, and atenolol in rabbits","volume":"17","author":"Fayyaz","year":"2020","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2020.09.051_bib28","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1177\/28.10.6775026","article-title":"Autoradiographic localization of carbonic anhydrase in the rabbit ciliary body","volume":"28","author":"Muther","year":"1980","journal-title":"J\u00a0Histochem Cytochem"},{"issue":"4","key":"10.1016\/j.xphs.2020.09.051_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ddr.430100407","article-title":"Carbonic anhydrase: general perspective and advances in glaucoma research","volume":"10","author":"Maren","year":"1987","journal-title":"Drug Dev Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920305827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920305827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:33:35Z","timestamp":1758360815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920305827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0022354920305827"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.051","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Ocular and Systemic Pharmacokinetics of Brinzolamide in Rabbits After Intracameral, Topical, and Intravenous Administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}